The Annals
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 18 January 2005, www.theannals.com, DOI 10.1345/aph.1E249.
The Annals of Pharmacotherapy: Vol. 39, No. 3, pp. 574-575. DOI 10.1345/aph.1E249
© 2005 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, A. M
Right arrow Articles by Sullivan, D. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, A. M
Right arrow Articles by Sullivan, D. L

Potential for toxicity with use of bitter orange extract and guarana for weight loss

Aleda M Hess, PharmD

Student Ohio Northern University Ada, Ohio 3423 Mapleway Drive Toledo, Ohio 43614-4137 a-hess1{at}onu.edu

Donald L Sullivan, PhD BS Pharm

Associate Professor of Pharmacy Practice Raabe College of Pharmacy Ohio Northern University

Published Online, January 18, 2005. www.theannals.com, DOI 10.1345/aph.1E249


TO THE EDITOR: With the recent Food and Drug Administration ban of the herbal weight-loss supplement ephedra, manufacturers of those products are switching to other ingredients, such as bitter orange extract and guarana. Four of the 5 top-selling weight-loss products (Metabolife, Hydroxycut, Dexatrim Natural, Xenadrine EFX) contain either bitter orange extract, guarana, or both.1 Are these replacements safe, or do they have the potential to cause harm?

Bitter orange extract comes from the Citrus aurantium plant. Its active components are synephrine, N-methyltyramine, and furocoumarins. The amount of synephrine can vary from 1% to 30% in products. Synephrine is an {alpha}-adrenergic agonist believed to cause weight loss by suppressing appetite and boosting metabolism. However, it can cause vasoconstriction through stimulation of {alpha}1 receptors, increasing mean arterial pressure. Synephrine also causes vasoconstriction and spasms in the coronary arteries, increasing heart rate and blood pressure. N-Methyltyramine, another component, can increase blood pressure by increasing norepinephrine release. The combination of synephrine and N-methyltyramine may have additive hypertensive effects and potential cardiotoxicity.2 The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure's Seventh Report even lists bitter orange as a cause of resistant hypertension.3 In one case report, a 55-year-old white female taking 300 mg of bitter orange extract daily had an acute myocardial infarction (AMI).4 The patient had no history of coronary artery disease, hypertension, or hyperlipidemia, but did have a 1.5 pack/day smoking history. Upon evaluation, the Naranjo probability scale found that bitter orange extract was the most likely source of her AMI.5 One final component in bitter orange, furocoumarins, like grapefruit, are believed to be the component that inhibits the CYP3A4 isoenzyme. Therefore, there are numerous potential drug interactions with drugs metabolized by CYP3A4 such as calcium-channel blockers, anti-fungals, and glucocorticoids.2,6

Guarana, another popular ingredient in weight-loss products, comes from the Paullinia cupana plant. The seed of guarana contains 2.5-7% caffeine (200 mg/dose). In comparison, coffee only contains 1-2% caffeine (100 mg/cup). As the dose in weight-loss supplements is titrated up, the patient may be taking as much as 1800 mg of caffeine a day. Caffeine acts as a central nervous system stimulant. In addition, it increases blood pressure and stimulates the release of catecholamines. Guarana in combination with drugs targeting the sympathetic nervous system, such as ß-adrenergic agonists and pseudoephedrine, or with other caffeine-containing substances, may have additive effects on blood pressure elevation. Guarana must be used cautiously and avoided in patients with hypertension and other cardiac conditions.2 A 25-year-old female with preexisting mitral valve prolapse drank Race 2005 Energy Blast with Guarana and Ginseng. She died of intractable ventricular fibrillation due to the high caffeine content.7

Few studies of any kind are available on either bitter orange or guarana. However, case reports regarding their safety are emerging since the weight-loss products have been reformulated. Their mechanisms of action and the case reports do not provide enough evidence about the safety of bitter orange extract and guarana. Over-the-counter weight-loss supplements should not be recommended for use until there are conclusive data.

References

  1. Walden G. How to fill a $1.5 billion hole. Chain Drug Rev 2004 (Apr 12):43 -4.
  2. Jellin JM, Gregory PJ, Batz F, Hitchens K, Bonakdar R, Scott GN, et al. Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. 4th ed. Stockton, CA: Therapeutic Research Faculty, 2002.
  3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA 2003;289:2560-72. Erratum 2003;290:197.[Abstract/Free Full Text]
  4. Nykamp DL, Fackih MN, Compton AL. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann Pharmacother 2004;38:812-6. DOI10.1345/aph.1D473[Abstract/Free Full Text]
  5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther 1981;30:239-45.[Medline]
  6. Huang SM, Hall SD, Watkins P, Love LA, Serabjit-Singh C, Betz JM, et al. Drug interactions with herbal products and grapefruit juice: a conference report. Clin Pharmacol Ther 2004;75:1-12.[CrossRef][Medline]
  7. Cannon ME, Cooks CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med J Aust 2001; 174:520-5.[Medline]




This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, A. M
Right arrow Articles by Sullivan, D. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, A. M
Right arrow Articles by Sullivan, D. L


homecopy help contact us subscription past issues search current issue